View Item 

Show simple item record

Weight loss decreases follicle stimulating hormone in overweight postmenopausal women
dc.contributor.authorKim, Catherineen_US
dc.contributor.authorRandolph, John F.en_US
dc.contributor.authorGolden, Sherita H.en_US
dc.contributor.authorLabrie, Fernanden_US
dc.contributor.authorKong, Shengchunen_US
dc.contributor.authorNan, Binen_US
dc.contributor.authorBarrett‐connor, Elizabethen_US
dc.date.accessioned2015-01-07T15:23:55Z
dc.date.available2016-03-02T19:36:56Zen
dc.date.issued2015-01en_US
dc.identifier.citationKim, Catherine; Randolph, John F.; Golden, Sherita H.; Labrie, Fernand; Kong, Shengchun; Nan, Bin; Barrett‐connor, Elizabeth (2015). "Weight loss decreases follicle stimulating hormone in overweight postmenopausal women." Obesity 23(1): 228-233.en_US
dc.identifier.issn1930-7381en_US
dc.identifier.issn1930-739Xen_US
dc.identifier.urihttps://hdl.handle.net/2027.42/109940
dc.publisherWiley Periodicals, Inc.en_US
dc.titleWeight loss decreases follicle stimulating hormone in overweight postmenopausal womenen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelEndocrinologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/109940/1/oby20917.pdf
dc.identifier.doi10.1002/oby.20917en_US
dc.identifier.sourceObesityen_US
dc.identifier.citedreferenceCampbell K, Foster‐Schubert K, Alfano C, et al. Reduced‐calorie dietary weight loss, exercise, and sex hormones in postmenopausal women: randomized controlled trial. J Clin Oncol 2012; 30: 2314 ‐ 2326.en_US
dc.identifier.citedreferenceDe Pergola G, Maldera S, Tartagni M, Pannacciulli N, Loverro G, Giorgino R. Inhibitory effect of obesity on gonadotropin, estradiol, and inhibin B levels in fertile women. Obesity (Silver Spring) 2006; 14: 1954 ‐ 1960.en_US
dc.identifier.citedreferenceKim C, Nan B, Laughlin G, et al. Endogenous sex hormone changes in postmenopausal women in the Diabetes Prevention Program. J Clin Endocrinol Metab 2012; 97: 2853 ‐ 2861.en_US
dc.identifier.citedreferenceGolden S, Dobs A, Vaidya D, et al. Endogenous sex hormones and glucose tolerance status in postmenopausal women. J Clin Endocrinol Metab 2007; 92: 1289 ‐ 1295.en_US
dc.identifier.citedreferenceDing E, Song Y, Malik V, Liu S. Sex differences of endogenous sex hormones and risk of type 2 diabetes. JAMA 2006; 295: 1288 ‐ 1299.en_US
dc.identifier.citedreferenceDing E, Song Y, Manson J, Rifai N, Buring J, Liu S. Plasma sex steroid hormones and risk of developing type 2 diabetes in women: A prospective study. Diabetologia 2007; 50: 2076 ‐ 2084.en_US
dc.identifier.citedreferenceKnowler W, Barrett‐Connor E, Fowler S, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393 ‐ 403.en_US
dc.identifier.citedreferenceMayer‐Davis E, Vitolins M, Carmiachael S, et al. Validity and reproducibility of a food frequency interview in a multi‐cultural epidemiology study. Ann Epidemiol 1999; 9: 314 ‐ 324.en_US
dc.identifier.citedreferenceKriska A, Caspersen C. Introduction to the collection of physical activity questionnaires. Med Sci Sports Exerc 1997; 29: 5 ‐ 9.en_US
dc.identifier.citedreferenceSodergard R, Backstrom T, Shanbhag V, Carstensen H. Calculation of free and bound fractions of testosterone and estradiol‐17 beta to human plasma proteins at body temperature. J Steroid Biochem 1982; 16: 801 ‐ 810.en_US
dc.identifier.citedreferenceKim C, Golden S, Mather K, et al. Racial/ethnic differences in sex hormone levels among postmenopausal women in the Diabetes Prevention Program. J Clin Endocrinol Metab 2012; 97: 4051 ‐ 4060.en_US
dc.identifier.citedreferenceGrenman S, Ronnemaa T, Iriala K, Kaihola H, Gronroos M. Sex steroid, gonadotropin, cortisol, and prolactin levels in healthy, massively obese women: correlation with abdominal fat cell size and effect of weight reduction. J Clin Endocrinol Metab 1986; 63: 1257 ‐ 1261.en_US
dc.identifier.citedreferenceWu A, Pike M, Stram D. Meta‐analysis: dietary fat intake, serum estrogen levels, and the risk of breast cancer. J Natl Cancer Inst 1999; 91: 529 ‐ 534.en_US
dc.identifier.citedreferenceMcTiernan A, Tworoger S, Ulrich C, et al. Effect of exercise on serum estrogens in postmenopausal women: a 12‐month randomized clinical trial. Cancer Res 2004; 64: 2923 ‐ 2928.en_US
dc.identifier.citedreferenceLiedtke S, Schmidt M, Vrieling A, et al. Postmenopausal sex hormones in relation to body fat distribution. Obesity (Silver Spring) 2012; 20: 1088 ‐ 1095.en_US
dc.identifier.citedreferenceSowers M, Eyvazzadeh A, McConnell D, et al. Anti‐mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition. J Clin Endocrinol Metab 2008; 93: 3478 ‐ 3483.en_US
dc.identifier.citedreferenceSowers M, McConnell D, Yosef M, Jannausch M, Harlow S, Randolph J Jr. Relating smoking, obesity, insulin resistance, and ovarian biomarker changes to the final menstrual period. Ann N Y Acad Sci 2010; 1204: 95 ‐ 103.en_US
dc.identifier.citedreferenceGracia C, Freeman E, Sammel M, Lin H, Nelson D. The relationship between obesity and race on inhibin B during the menopause tradition. Menopause 2005; 12: 559 ‐ 566.en_US
dc.identifier.citedreferenceSowers M, Wildman R, Mancuso P, et al. Change in adipocytokines and ghrelin with menopause. Maturitas 2008; 59: 149 ‐ 157.en_US
dc.identifier.citedreferenceGarin M, Burns C, Kaul S, Cappola A. Clinical review: the human experience with ghrelin administration. J Clin Endocrinol Metab 2013; 98: 1826 ‐ 1837.en_US
dc.identifier.citedreferenceFreeman E, Sammel M, Lin H, Gracia C. Obesity and reproductive hormone levels in the transition to menopause. Menopause 2010; 17: 718 ‐ 726.en_US
dc.identifier.citedreferenceTepper P, Randolph J, McConnell D, et al. Trajectory clustering of estradiol and follicle‐stimulating hormone during the menopausal transition among women in the Study of Women's Health Across the Nation. J Clin Endocrinol Metab 2012; 97: 2872 ‐ 2880.en_US
dc.identifier.citedreferenceEndogenous Hormones Breast Cancer Collaborative Group. Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst 2003; 95: 1218 ‐ 1226.en_US
dc.identifier.citedreferenceKarim R, Mack W, Hodis H, Roy S, Stanczyk F. Influence of age and obesity on serum estradiol, estrone, and sex hormone binding globulin concentrations following oral estrogen administration in postmenopausal women. J Clin Endocrinol Metab 2009; 94: 4136 ‐ 4143.en_US
dc.identifier.citedreferenceLambrinoudaki I, Armeni E, Rizos D, et al. Sex hormones in postmenopausal women receiving low‐dose hormone therapy: the effect of BMI. Obesity (Silver Spring) 2011; 19: 988 ‐ 993.en_US
dc.identifier.citedreferenceWaaseth M, Bakken K, Dumeaux V, et al. Hormone replacement therapy use and plasma levels of sex hormones in the Norwegian Women and Cancer Postgenome Cohort—a cross‐sectional analysis. BMC Women's Health 2008; 1, doi: 10.1186/1472-6874-8-1.en_US
dc.identifier.citedreferencePasquali R. Obesity and androgens: facts and perspectives. Fertil Steril 2006; 85: 1319 ‐ 1340.en_US
dc.identifier.citedreferenceFlegal K, Carroll M, Kit B, Ogden C. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999‐2010. JAMA 2012; 307: 491 ‐ 497.en_US
dc.identifier.citedreferenceWildman R, Tepper P, Crawford S, et al. Do changes in sex steroid hormones precede or follow increases in body weight during the menopause transition? Results from the Study of Women's Health Across the Nation. J Clin Endocrinol Metab 2012; 97: 1695 ‐ 1704.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
oby20917.pdf
Size:
142.4KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.